Donepezil hydrochloride
Donepezil Hydrochloride is a prescription medication used to treat symptoms of Alzheimer's disease by improving memory and thinking skills. It comes as a 23 mg oral tablet, available in 30 or 90-count bottles. Manufactured by Edenbridge Pharmaceuticals LLC. under application ANDA203713. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Donepezil Hydrochloride is a prescription medication used to treat symptoms of Alzheimer's disease by improving memory and thinking skills. It comes as a 23 mg oral tablet, available in 30 or 90-count bottles. Manufactured by Edenbridge Pharmaceuticals LLC. under application ANDA203713. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Donepezil hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Donepezil hydrochloride — ANDA 020690 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020690"
}
]
|
| identifier | ANDA020690 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"fda",
"health-care",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Donepezil hydrochloride |
